Technology is based on tissue changes that evidence years before tumor presentation
Scalable technology that is easily replicated at much lower cost
Three clinical trials with over 650 women trained and validated the FWs Neural Nets
Self learning bioinformatics algorithms that learn from each new case to refine outcomes
Adds scientific analytical comparisons to biopsy analysis using BTA Early AlertTM reports
Collection device is a small package with sixteen sensors
Device does not interfere with daily activities
Benefits
The First Warning SystemTM is:
Improved quality of care because it is non-radiogenic, non-invasive, and non-toxic
Testing and retesting is encouraged because FWS is low cost and non-invasive
Post market feedback to build a personal breast tissue history -- Breast Health NowTM
Industry leading false positives
Office-based with capital equipment investment of less than $1,000.
Requires a minimum time to learn its application—no specialized medical training.
Designed to be used at the point of entry of women into the medical care system: free standing clinics, offices of general practitioners, obstetricians, gynecologists, internists and other similar places.
Has the potential of Over-The-Counter applications
Disruptive economics for the patient and medical delivery system
Get in Touch
First Warning Systems, Inc.
1325 Airmotive Way,
Ste 175-L Reno, NV 89502
